RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000071.xml
Semin Neurol 2016; 36(06): 607-614
DOI: 10.1055/s-0036-1592356
DOI: 10.1055/s-0036-1592356
Review Article
Movement Disorders in the Intensive Care Unit
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
01. Dezember 2016 (online)
Abstract
Movement disorders are common; yet to those without subspecialty experience they can be difficult to recognize, categorize, and manage. Although most frequently encountered in an outpatient setting, patients with movement disorders are commonly hospitalized and often admitted to the intensive care unit, leading to possible confusion about their proper care. In addition, movement disorders can arise in critical care settings for several reasons, including medication side effects, substance withdrawal, or development of a new syndrome. In this review, the authors explore the management of critically ill patients with movement disorders, new or established, including differential diagnosis, work-up, and treatment.
-
References
- 1 Elias WJ, Shah BB. Tremor. JAMA 2014; 311 (9) 948-954
- 2 Robottom BJ, Factor SA, Weiner WJ. Movement disorders emergencies Part 2: hyperkinetic disorders. Arch Neurol 2011; 68 (6) 719-724
- 3 Wijdicks EF, Parisi JE, Sharbrough FW. Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol 1994; 35 (2) 239-243
- 4 Greer DM, Rosenthal ES, Wu O. Neuroprognostication of hypoxic-ischaemic coma in the therapeutic hypothermia era. Nat Rev Neurol 2014; 10 (4) 190-203
- 5 Greer DM. Unexpected good recovery in a comatose post-cardiac arrest patient with poor prognostic features. Resuscitation 2013; 84 (6) e81-e82
- 6 Celesia GG, Grigg MM, Ross E. Generalized status myoclonicus in acute anoxic and toxic-metabolic encephalopathies. Arch Neurol 1988; 45 (7) 781-784
- 7 Lucas JM, Cocchi MN, Salciccioli J , et al. Neurologic recovery after therapeutic hypothermia in patients with post-cardiac arrest myoclonus. Resuscitation 2012; 83 (2) 265-269
- 8 English WA, Giffin NJ, Nolan JP. Myoclonus after cardiac arrest: pitfalls in diagnosis and prognosis. Anaesthesia 2009; 64 (8) 908-911
- 9 Leite MA, Orsini M, de Freitas MR , et al. Another perspective on fasciculations: when is it not caused by the classic form of amyotrophic lateral sclerosis or progressive spinal atrophy?. Neurol Int 2014; 6 (3) 5208
- 10 Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg 2004; 107 (1) 1-16
- 11 Beckmann YY, Ciftçi Y, Seçil Y, Eren S. Fasciculations in brain death. Crit Care Med 2010; 38 (12) 2377-2378
- 12 Walker RH. Chorea. Continuum (Minneap Minn) 2013; 19 (5 Movement Disorders): 1242-1263
- 13 Wild EJ, Tabrizi SJ. The differential diagnosis of chorea. Pract Neurol 2007; 7 (6) 360-373
- 14 Medlock MD, Cruse RS, Winek SJ , et al. A 10-year experience with postpump chorea. Ann Neurol 1993; 34 (6) 820-826
- 15 Surie S, Tijssen MA, Biervliet JD , et al. Chorea in adults following pulmonary endarterectomy. Move disord 2010; 25: 1101-1104
- 16 Jinnah HA, Factor SA. Diagnosis and treatment of dystonia. Neurol Clin 2015; 33 (1) 77-100
- 17 Manji H, Howard RS, Miller DH , et al. Status dystonicus: the syndrome and its management. Brain 1998; 121 (Pt 2): 243-252
- 18 Teive HA, Munhoz RP, Souza MM , et al. Status dystonicus: study of five cases. Arq Neuropsiquiatr 2005; 63 (1) 26-29
- 19 Mehta SH, Morgan JC, Sethi KD. Drug-induced movement disorders. Neurol Clin 2015; 33 (1) 153-174
- 20 Mallick IH, Winslet MC. A review of the epidemiology, pathogenesis and management of tetanus. Int J Surg 2004; 2 (2) 109-112
- 21 Maganti R, Gerber P, Drees C, Chung S. Nonconvulsive status epilepticus. Epilepsy Behav 2008; 12 (4) 572-586
- 22 Meierkord H, Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol 2007; 6 (4) 329-339
- 23 Hinson HE, Sheth KN. Manifestations of the hyperadrenergic state after acute brain injury. Curr Opin Crit Care 2012; 18 (2) 139-145
- 24 Diamond AL, Callison RC, Shokri J, Cruz-Flores S, Kinsella LJ. Paroxysmal sympathetic storm. Neurocrit Care 2005; 2 (3) 288-291
- 25 Munhoz RP, Scorr LM, Factor SA. Movement disorders emergencies. Curr Opin Neurol 2015; 28 (4) 406-412
- 26 Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985; 142 (10) 1137-1145
- 27 Robottom BJ, Weiner WJ, Factor SA. Movement disorders emergencies. Part 1: hypokinetic disorders. Arch Neurol 2011; 68 (5) 567-572
- 28 Heytens L, Forget P, Scholtès JL, Veyckemans F. The changing face of malignant hyperthermia: less fulminant, more insidious. Anaesth Intensive Care 2015; 43 (4) 506-511
- 29 American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Association; 2013
- 30 Wijemanne S, Jankovic J. Movement disorders in catatonia. J Neurol Neurosurg Psychiatry 2014; 87: 220-221
- 31 Saddawi-Konefka D, Berg SM, Nejad SH, Bittner EA. Catatonia in the ICU: an important and underdiagnosed cause of altered mental status. a case series and review of the literature*. Crit Care Med 2014; 42 (3) e234-e241
- 32 Ahlskog JE. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls. Mayo Clin Proc 2014; 89 (7) 997-1003
- 33 Cooper MK, Brock DG, McDaniel CM. Interaction between levodopa and enteral nutrition. Ann Pharmacother 2008; 42 (3) 439-442
- 34 Bonnici A, Ruiner CE, St-Laurent L, Hornstein D. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay. Ann Pharmacother 2010; 44 (9) 1504-1507
- 35 Mizuno J, Kato S, Watada M, Morita S. [Perioperative management of a patient with Parkinson's disease with intravenous infusion of levodopa]. Masui 2009; 58 (10) 1286-1289
- 36 Wright JJ, Goodnight PD, McEvoy MD. The utility of ketamine for the preoperative management of a patient with Parkinson's disease. Anesth Analg 2009; 108 (3) 980-982
- 37 Sharma JC, Macnamara L, Hasoon M, Vassallo M. Diagnostic and therapeutic value of apomorphine in Parkinsonian patients. Int J Clin Pract 2004; 58 (11) 1028-1032
- 38 Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 2001; 345 (26) 1870-1876
- 39 Sidransky MA, Tran NV, Kaye AD. Anesthesia considerations in stiff person syndrome. Middle East J Anaesthesiol 2013; 22 (2) 217-221
- 40 Turner MR, Irani SR, Leite MI, Nithi K, Vincent A, Ansorge O. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology 2011; 77 (5) 439-443
- 41 Davies G, Irani SR, Coltart C , et al. Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med 2010; 38 (2) 679-682
- 42 Howard CM, Kass JS, Bandi VD, Guntupalli KK. Challenges in providing critical care for patients with anti-N-methyl-D-aspartate receptor encephalitis. Chest 2014; 145 (5) 1143-1147
- 43 Malter MP, Elger CE, Surges R. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis. Seizure 2013; 22 (2) 136-140
- 44 Mann AP, Grebenciucova E, Lukas RV. Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges. Ther Clin Risk Manag 2014; 10: 517-525
- 45 Mittal MK, Rabinstein AA, Hocker SE, Pittock SJ, , M Wijdicks E, McKeon A. Autoimmune encephalitis in the ICU: analysis of phenotypes, serologic findings, and outcomes. Neurocrit Care 2016; 24 (2) 240-250
- 46 Jankovic J, Fahn S. Physiologic and pathologic tremors. Diagnosis, mechanism, and management. Ann Intern Med 1980; 93 (3) 460-465